他泽司他有几种规格?多少钱?

Tazerestat is a methyltransferase inhibitor used to treat certain cancers, primarily patients with epithelioid sarcoma and follicular lymphoma. This article will introduce the relevant information of tazerestat in detail from three aspects: specifications, price and safety. By understanding these contents, patients and families can better choose appropriate treatment options.

Tazerestat is available in several specifications

The specifications are relatively single and are mainly supplied in the form of tablets. According to the package insert, the dosage form and strength are clearly 200 mg film-coated tablets. This strength is designed to make it easier for patients to adjust the dosage according to medical advice.

Main specifications

The standard specification of tazerestat is 200 mg/tablet, and each bottle usually contains 240 tablets. This design can meet the needs of long-term treatment and reduce the trouble of frequent drug purchase.

Other packaging forms

In addition to standard packaging, there are other forms of packaging on the market, such as 56-piece packages and 80-piece packages. These packages are usually produced by pharmaceutical companies in different regions to meet the needs of different patients.

Understanding the specifications of tazerestat can help patients and doctors develop a reasonable medication plan to ensure continuity of treatment.

How much does the different specifications of tazerestat cost?

The price of tazerestat varies depending on the specifications and manufacturers. The following are reference prices for several common specifications.

Laos Lucius Version

The specification of Tazerestat produced by Laos Lucius is 200mg*56 tablets, with a reference price of about US$777 per box. This strength is suitable for patients during short-term treatment or dose adjustment phases.

Lao Big Bear Version

The Lao Big Bear Version of tazerestat is available in 200mg*80 tablets, priced at approximately US$1,480 per box. This strength is suitable for patients requiring moderate dose therapy.

Export Hong Kong version

For consumers who need larger packaging, the export Hong Kong version of the original version of tazerestat provides a large-capacity option of 200mg*240 tablets, with a price of approximately US$7,213. This specification is suitable for patients undergoing long-term treatment and can reduce the frequency of drug purchase.

Price is an important reference factor when choosing drugs. Patients can choose appropriate specifications based on their own economic conditions and treatment needs.

How safe is tazerestat?

Tazerestat has shown certain efficacy in the treatment of specific cancers, but its safety issues cannot be ignored. The following is a detailed analysis of its safety.

Common adverse reactions

According to clinical trial data, tazerestat may cause pain, fatigue, nausea, decreased appetite and other adverse reactions. These reactions are usually mild to moderate but require close monitoring.

Serious Risks

Tazerestat may increase the risk of secondary malignancies, such as myelodysplastic syndromes and acute leukemia. Patients need to have regular blood tests while taking the medication.

Precautions for special groups

Pregnant and breastfeeding women should avoid using tazerestat as it may cause harm to the fetus or infant. Patients of childbearing age need to take effective contraceptive measures.

Understanding the safety of tazerestat can help patients and doctors weigh the pros and cons and develop personalized treatment plans.